Swiss Acino buys Litha Health­care

The Star Early Edition - - BUSINESS NEWS - Sandile Mchunu

SWISS phar­ma­ceu­ti­cal com­pany Acino an­nounced that it has ac­quired South Africa’s Litha Health­care for an undis­closed amount.

Litha pro­vides ser­vices and prod­ucts to pub­lic and pri­vate hos­pi­tals, phar­ma­cies, gen­eral and spe­cial­ist prac­ti­tion­ers, as well as gov­ern­ment law en­force­ment pro­grammes.

Litha is also part of Endo In­ter­na­tional, a global spe­cial­ity phar­ma­ceu­ti­cal com­pany, fo­cused on im­prov­ing pa­tients’ lives, while cre­at­ing share­holder value.

Acino chief ex­ec­u­tive Kalle Känd said the ac­qui­si­tion would en­able Acino to en­trench its foot­prints in the African mar­ket.

“We have cho­sen Litha as they have a strong po­si­tion in the mar­ket and a solid rep­u­ta­tion in sev­eral ther­a­peu­tic ar­eas that are strate­gic for Acino. With its well-es­tab­lished prod­uct pipe­line and its long-stand­ing re­la­tion­ships with li­cens­ing part­ners, Litha of­fers very promis­ing prospects for the fu­ture,” said Känd.

Litha will pro­vide Acino with im­me­di­ate ac­cess and a strong pres­ence in the South African mar­ket, which is key for Acino to be­come a sig­nif­i­cant player in Africa.

Acino will bring ad­vanced health­care prod­ucts and ex­per­tise to South Africans.

Pri­mary care

Litha’s ex­ist­ing prod­uct port­fo­lio com­prises nearly 100 of­fer­ings fo­cus­ing on pri­mary care, largely through orig­i­na­tor prod­ucts, and spe­cial­ity care, partly through generic prod­ucts. Litha’s foren­sic busi­ness pro­vides the SAPS with DNA ev­i­dence col­lec­tion and crime-scene kits.

Litha is set for growth as it has a strong pipe­line of 124 prod­ucts that are ex­pected to be launched within the next five years. Acino plans to com­ple­ment the port­fo­lio by launch­ing a se­lec­tion of their ex­ist­ing prod­ucts in South Africa in the up­com­ing years.

Litha man­ag­ing di­rec­tor Guil­laume van Niek­erk said: “We look for­ward to join­ing Acino as we con­tinue to add value to our cus­tomers and pos­i­tively im­pact pa­tients’ lives. The syn­er­gies be­tween the or­gan­i­sa­tions will fur­ther sup­port our vi­sion of be­ing one of the top 10 pharma com­pa­nies in South Africa.”

Acino’s con­fi­dence in South Africa and Litha’s strong po­si­tion in the mar­ket bode well for this col­lab­o­ra­tion that aims to main­tain and fur­ther grow the phar­ma­ceu­ti­cal busi­ness in South Africa.

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.